ARGENT BIOPHARMA LTD.ARGENT BIOPHARMA LTD.ARGENT BIOPHARMA LTD.

ARGENT BIOPHARMA LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪8.54 M‬EUR
−0.334EUR
‪−10.91 M‬EUR
‪554.55 K‬EUR
‪47.19 M‬
Beta (1Y)
−0.83

About ARGENT BIOPHARMA LIMITED


CEO
Roby Reuven Zomer
Headquarters
Subiaco
Founded
2005
ISIN
AU0000326647
FIGI
BBG000QJC3S9
Argent BioPharma Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Roby Zomer on October 21, 2005 and is headquartered in Perth, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ARGENT BIOPHARMA LTD. stocks are traded under the ticker H5O0.
H5O0 reached its all-time high on Oct 3, 2024 with the price of 0.322 EUR, and its all-time low was 0.112 EUR and was reached on Aug 6, 2024. View more price dynamics on H5O0 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ARGENT BIOPHARMA LTD. financials in yearly and quarterly reports right on TradingView.
ARGENT BIOPHARMA LTD. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
H5O0 net income for the last half-year is ‪−6.51 M‬ EUR, while the previous report showed ‪−4.36 M‬ EUR of net income which accounts for −49.06% change. Track more ARGENT BIOPHARMA LTD. financial stats to get the full picture.
No, H5O0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARGENT BIOPHARMA LTD. EBITDA is ‪−10.19 M‬ EUR, and current EBITDA margin is ‪−1.90 K‬%. See more stats in ARGENT BIOPHARMA LTD. financial statements.
Like other stocks, H5O0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARGENT BIOPHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.